U Akesolo, M I Maguregui, L González, R M Jiménez, R M Alonso
Index: J. Chromatogr. Sci. 42(2) , 74-9, (2004)
Full Text: HTML
Experimental design methodologies are applied to the development of a capillary zone electrophoretic method for the separation of the angiotensin-converting enzyme inhibitor enalapril and its derivative enalaprilat and the diuretics xipamide and hydrochlorothiazide. The effects of pH, buffer concentration, proportion of boric acid in the mixed boric acid-potassium dihydrogen phosphate background electrolyte, temperature, applied voltage, and percentage of organic modifier are studied. Critical factors are identified in a screening design (a 2(6-2) fractional factorial design), and afterwards, optimal conditions for the separation are reached by means of an optimization design (a 2(2) + 2 x 2 + k central composite design). The studied response is the resolution between peaks. The four studied compounds can be separated in less than 3.5 min using an electrolyte of 20mM boric acid-potassium dihydrogen phosphate (75:25, v/v) with 5% MeOH adjusted to pH 8.0 with KOH, at a potential of 30 kV. The detection wavelength and temperature are 206 nm and 35 degrees C, respectively.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Xipamide
CAS:14293-44-8 |
C15H15ClN2O4S |
Clinicopharmacological reappraisal of the potency of diureti...
1993-01-01 [Cardiovasc. Drugs Ther. 7 Suppl 1 , 23-8, (1993)] |
Bioavailability study of triamterene and xipamide using urin...
2012-03-05 [J. Pharm. Biomed. Anal. 61 , 78-85, (2012)] |
Spectrophotometric and spectrodensitometric determination of...
2010-03-01 [Drug Test. Anal. 2(3) , 113-21, (2010)] |
Liver cirrhosis with ascites: pathogenesis of resistance to ...
1994-01-01 [Cardiology 84 Suppl 2 , 87-98, (1994)] |
Selective and sensitive spectrophotometric method for the de...
2012-11-01 [Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 97 , 284-9, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved